Rizatriptan Should NOT Be Used During Pregnancy
Rizatriptan is contraindicated in pregnancy and should be avoided. The most recent 2025 American College of Physicians guidelines explicitly state that their recommendations for triptans (including rizatriptan) apply only to "nonpregnant outpatient adults," and emphasize the need to "discuss the adverse effects of pharmacologic treatments during pregnancy and lactation" in people of childbearing potential 1. The FDA drug label for rizatriptan states that it "should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus" 2.
Recommended Treatment Algorithm for Migraine in Pregnancy
First-Line Approach
- Paracetamol (acetaminophen) 1000 mg, preferably as a suppository, is the first-choice drug treatment 3, 4
- This is the safest pharmacologic option across all trimesters
Second-Line Options (If Paracetamol Fails)
- NSAIDs (aspirin, ibuprofen) can be used episodically during the first and second trimesters only
- Must be avoided in the third trimester due to risks of premature closure of ductus arteriosus and bleeding complications 3, 4
Third-Line (Second/Third Trimester Only)
- Sumatriptan is the only triptan with any safety data in pregnancy, showing no additional risk of birth defects compared to the general population (3-5% baseline) 5, 6
- Recent evidence suggests triptans may be considered as second-line treatment "at any term and under normal conditions of use," though this remains controversial 7
- Rizatriptan specifically lacks pregnancy safety data and should not be used when sumatriptan is available
For Nausea/Vomiting
- Prochlorperazine is unlikely to be harmful 3
- Metoclopramide is acceptable in second and third trimesters 3
Critical Contraindications in Pregnancy
Absolutely avoid:
- Ergot alkaloids (dihydroergotamine, ergotamine) - teratogenic 3, 8
- Valproate and topiramate - known teratogenicity 6
- All triptans except sumatriptan (which has limited data) 3
- Opioids and butalbital (per general migraine guidelines) 1
Prophylaxis (Rarely Indicated)
If prophylaxis is absolutely necessary (≥3 severe attacks/month unresponsive to acute treatment):
- Metoprolol or propranolol (beta-blockers) are safest options 3, 9
- Low-dose amitriptyline may be considered 4
- Magnesium is a safe alternative 9
- Use only in second and third trimesters when possible 8
Key Clinical Considerations
Non-pharmacologic approaches should always be attempted first:
- Relaxation techniques, sleep optimization, massage, ice packs, biofeedback 3
- These are particularly important in the first trimester when fetal organogenesis occurs
Timing matters critically:
- First trimester carries highest teratogenic risk
- Most women experience improvement in migraine during second and third trimesters (55-90%) 3
- Attacks often worsen postpartum due to rapid estrogen decline 3
Common pitfall: Assuming all triptans have equivalent safety profiles in pregnancy. They do not. Only sumatriptan has meaningful pregnancy registry data 5, 6. Rizatriptan lacks this evidence base.
Risk-benefit consideration: Untreated severe migraine with associated nausea, vomiting, dehydration, and hypotension may pose greater maternal and fetal risks than appropriate medication use 4, 8. However, this justifies paracetamol or carefully selected NSAIDs—not rizatriptan.